Keywords: تداوم آنتی بادی; Rheumatoid arthritis; Immunosuppressive therapy; 13-valent pneumococcal conjugate vaccine; Immunogenicity; Antibody persistence; RA; Rheumatoid arthritis patients; HC; Healthy control subjects; PnPS; pneumococcal polysaccharides; PCV13; 13-valent pneumoco
مقالات ISI تداوم آنتی بادی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تداوم آنتی بادی; Maternal vaccination; Neonatal pertussis; Antibody persistence; Infant vaccination;
Keywords: تداوم آنتی بادی; Booster; Vaccine; Immunogenicity; Safety; Tdpa; acellular pertussis vaccine; Antibody persistence; Aluminium; AE; adverse event; ATP; according to protocol; BR; booster response; CI; confidence interval; DT; diphtheria toxoid; dTpa; reduced antigen conten
Keywords: تداوم آنتی بادی; Antibody persistence; Conjugate vaccine; Hyporesponsiveness; Memory; Pneumococcus; Polysaccharide;
Humoral immunity 10â¯years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA
Keywords: تداوم آنتی بادی; Diphtheria; Tetanus; Pertussis; Antibody persistence;
Antibody persistence and booster response 68â¯months after vaccination at 2-10â¯years of age with one dose of MenACWY-TT conjugate vaccine
Keywords: تداوم آنتی بادی; AEs; adverse events; ATP; according-to-protocol; CIs; confidence intervals; GI; gastrointestinal; GMTs; geometric mean titers; hSBA; serum bactericidal activity assay using human complement; IMD; invasive meningococcal disease; M; month; MenB; meningococc
Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial
Keywords: تداوم آنتی بادی; Antibody persistence; Meningococcal B vaccine; Infants; Children; Booster response; 2Â +Â 1 schedule; Safety; Open-label randomised clinical trial; AE; adverse event; CI; confidence interval; FAS; full analysis set; fHbp; factor H-binding protein; GMT; ge
Antibody persistence in children aged 6-7Â years one year following booster immunization with two MMR vaccines applied by aerosol or by injection
Keywords: تداوم آنتی بادی; Antibody persistence; Aerosol; Booster immunization; MMR vaccine; Edmonston-Zagreb; Attenuvax; Leningrad-Zagreb; Jerryl-Lynn;
Modeling the long-term antibody response of a hepatitis E vaccine
Keywords: تداوم آنتی بادی; Hepatitis E vaccine; Antibody persistence; Mathematical models; ImmunogenicityHE, hepatitis E; HEV, hepatitis E virus; ORF, open reading frame; WU, World Health Organization units; ELISA, enzyme-linked immunosorbent assay; GMC, geometric mean concentratio
Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination
Keywords: تداوم آنتی بادی; NCT01823536; Meningococcal vaccine; Childhood vaccination; Antibody persistence; Booster vaccination; hSBA; serum bactericidal assay using human complement; CRM197; non-toxic mutant of diphtheria toxin; IMD; invasive meningococcal disease; GMT; geometric
Diphtheria, tetanus and poliovirus antibody persistence 5 years after vaccination of pre-schoolers with two different diphtheria, tetanus and inactivated poliomyelitis vaccines (Td-IPV or DT-IPV) and immune responses to a booster dose of DTaP-IPV
Keywords: تداوم آنتی بادی; Vaccines; Booster response; Td-IPV; DT-IPV; DTaP-IPV; Antibody persistence; Safety; ANSM; Agence Nationale de Sécurité du Médicament et des Produits de Santé (the French national agency for the safety of drugs and health products); aP; standard dose o
Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel
Keywords: تداوم آنتی بادی; ACIP; Advisory Committee on Immunization Practices; CDC; Centers for Disease Control and Prevention; DMSS; Defense Medical Surveillance System; DoD; Department of Defense; DoDSR; Department of Defense Serum Repository; ELISA; enzyme-linked immunosorbent a
Persistence of antibodies for 42 months following vaccination of adolescents with a meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine (MenACWY-TT)
Keywords: تداوم آنتی بادی; Neisseria meningitidis; Conjugate vaccines; Tetravalent meningococcal vaccine; Adolescents; Antibody persistence;
Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamo
Keywords: تداوم آنتی بادی; AE; adverse event; ATP; according-to-protocol; BS; blood sample; CPS; capsular polysaccharide; CI; confidence interval; DTPa-HBV-IPV/Hib; combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae
Factors associated with seroimmunity against tick borne encephalitis virus 10 years after booster vaccination
Keywords: تداوم آنتی بادی; Tick borne encephalitis; Antibody persistence; Long-term; Follow-up; Immunization schedule; Booster properties
Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine
Keywords: تداوم آنتی بادی; Japanese encephalitis; Antibody persistence; Statistical model; Duration of protection;
Pneumococcal polysaccharide 23-valent vaccine: Long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults
Keywords: تداوم آنتی بادی; Pneumococcal vaccine; Streptococcus pneumoniae; Antibody persistence; Revaccination; Vaccine safety; Polysaccharide vaccine;
Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV)
Keywords: تداوم آنتی بادی; Rabies; Post-exposure prophylaxis; Antibody persistence
Antibody persistence six years after two doses of combined hepatitis A and B vaccine
Keywords: تداوم آنتی بادی; Antibody persistence; Long-term protection; Combined hepatitis A and hepatitis B vaccine
Antibody persistence in young adults 1 year after MMR immunization by aerosol or by subcutaneous route
Keywords: تداوم آنتی بادی; MMR aerosol vaccine; Seropositivity; Seroresponse; Antibody persistence;
Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: Immunogenicity 5 years post-vaccination
Keywords: تداوم آنتی بادی; Antibody persistence; Diphtheria; Tetanus; Pertussis; Adult;
Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses
Keywords: تداوم آنتی بادی; HPV-16/18; VLP vaccine; Antibody persistence; Statistical models; Immunologic memory; Cervical cancer
Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies
Keywords: تداوم آنتی بادی; Oral polio vaccine; Antibody persistence; Seroprevalence; Vaccination coverage
Serological detection of anti-Trichinella antibodies in wild foxes and experimentally infected farmed foxes in Norway
Keywords: تداوم آنتی بادی; Antibody persistence; Excretory/secretory antigen; Indirect ELISA; Seroprevalence; Surveillance; Trichinellosis; Trichinella nativa; Tyvelose antigen; Western blot; Wildlife;
Antibody persistence following booster vaccination against tick-borne encephalitis: 3-Year post-booster follow-up
Keywords: تداوم آنتی بادی; Tick-borne encephalitis; Vaccination; Booster interval; Antibody persistence; Long-term follow-up; Low-responsiveness
One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine
Keywords: تداوم آنتی بادی; Acellular pertussis; Haemophilus influenzae type b; Inactivated polio vaccine; Fully liquid pentavalent vaccine; Antibody persistence; Booster response
Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up
Keywords: تداوم آنتی بادی; Children; Hepatitis A vaccine; Antibody persistence